Worldwide Clinical Practice of High-Flow Nasal Cannula and Concomitant Aerosol Therapy in the Adult ICU Setting

References

1. 1.↵
   1. Rochwerg B,
   2. Einav S,
   3. Chaudhuri D,
   4. Mancebo J,
   5. Mauri T,
   6. Helviz Y,
   7. et al

   . The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med 2020;46(12):2226-2237.

   OpenUrl
2. 2.↵
   1. Li J,
   2. Jing G,
   3. Scott JB

   . Year in review 2019: high-flow nasal cannula oxygen therapy for adult subjects. Respir Care 2020;65(4):545-557.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Rochwerg B,
   2. Granton D,
   3. Wang DX,
   4. Helviz Y,
   5. Einav S,
   6. Frat JP,
   7. et al

   . High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med 2019;45(5):563-572.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Granton D,
   2. Chaudhuri D,
   3. Wang D,
   4. Einav S,
   5. Helviz Y,
   6. Mauri T,
   7. et al

   . High-flow nasal cannula compared with conventional oxygen therapy or noninvasive ventilation immediately postextubation: a systematic review and meta-analysis. Crit Care Med 2020;48(11):e1129-e1136.

   OpenUrl
5. 5.↵
   1. Chaudhuri D,
   2. Granton D,
   3. Wang DX,
   4. Burns KEA,
   5. Helviz Y,
   6. Einav S,
   7. et al

   . High-flow nasal cannula in the immediate postoperative period: a systematic review and meta-analysis. Chest 2020;158(5):1934-1946.

   OpenUrl
6. 6.↵
   1. Leone M,
   2. Einav S,
   3. Chiumello D,
   4. Constantin JM,
   5. De Robertis E,
   6. De Abreu MG,
   7. et al.

   , Guideline contributors. Noninvasive respiratory support in the hypoxaemic peri-operative/periprocedural patient: a joint ESA/ESICM guideline. Intensive Care Med 2020;46(4):697-713.

   OpenUrl
7. 7.↵
   1. Sang L,
   2. Nong L,
   3. Zheng Y,
   4. Xu Y,
   5. Chen S,
   6. Zhang Y,
   7. et al

   . Effect of high-flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation for preventing reintubation: a Bayesian network meta-analysis and systematic review. J Thorac Dis 2020;12(7):3725-3736.

   OpenUrl
8. 8.↵
   1. Frat JP,
   2. Thille AW,
   3. Mercat A,
   4. Girault C,
   5. Ragot S,
   6. Perbet S,
   7. et al.

   , REVA Network. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185-2196.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Fong KM,
   2. Au SY,
   3. Ng GWY

   . Preoxygenation before intubation in adult patients with acute hypoxemic respiratory failure: a network meta-analysis of randomized trials. Crit Care 2019;23(1):319.

   OpenUrl
10. 10.↵
    1. Cortegiani A,
    2. Crimi C,
    3. Sanfilippo F,
    4. Noto A,
    5. Di Falco D,
    6. Grasselli G,
    7. et al

    . High flow nasal therapy in immunocompromised patients with acute respiratory failure: a systematic review and meta-analysis. J Crit Care 2019;50:250-256.

    OpenUrl
11. 11.↵
    1. Fraser JF,
    2. Spooner AJ,
    3. Dunster KR,
    4. Anstey CM,
    5. Corley A

    . Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax 2016;71(8):759-761.

    OpenUrlAbstract/FREE Full Text
12. 12.
    1. Li XY,
    2. Tang X,
    3. Wang R,
    4. Yuan X,
    5. Zhao Y,
    6. Wang L,
    7. et al

    . High-flow nasal cannula for chronic obstructive pulmonary disease with acute compensated hypercapnic respiratory failure: a randomized, controlled trial. Int J Chron Obstruct Pulmon Dis 2020;15:3051-3061.

    OpenUrl
13. 13.
    1. Jing G,
    2. Li J,
    3. Hao D,
    4. Wang T,
    5. Sun Y,
    6. Tian H,
    7. et al

    . Comparison of high flow nasal cannula with noninvasive ventilation in chronic obstructive pulmonary disease patients with hypercapnia in preventing postextubation respiratory failure: a pilot randomized controlled trial. Res Nurs Health 2019;42(3):217-225.

    OpenUrl
14. 14.
    1. Fu C,
    2. Liu X,
    3. Zhu Q,
    4. Wu X,
    5. Hao S,
    6. Xie L,
    7. et al

    . Efficiency of high-flow nasal cannula on pulmonary rehabilitation in COPD patients: a meta-analysis. Biomed Res Int 2020;2020:7097243.

    OpenUrl
15. 15.↵
    1. Elshof J,
    2. Duiverman ML

    . Clinical evidence of nasal high-flow therapy in chronic obstructive pulmonary disease patients. Respiration 2020;99(2):140-153.

    OpenUrlPubMed
16. 16.↵
    1. Mauri T,
    2. Alban L,
    3. Turrini C,
    4. Cambiaghi B,
    5. Carlesso E,
    6. Taccone P,
    7. et al

    . Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med 2017;43(10):1453-1463.

    OpenUrlPubMed
17. 17.↵
    1. Mauri T,
    2. Turrini C,
    3. Eronia N,
    4. Grasselli G,
    5. Volta CA,
    6. Bellani G,
    7. Pesenti A

    . Physiologic effects of high-flow nasal cannula in acute hypoxemic respiratory failure. Am J Respir Crit Care Med 2017;195(9):1207-1215.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Biselli P,
    2. Fricke K,
    3. Grote L,
    4. Braun AT,
    5. Kirkness J,
    6. Smith P,
    7. et al

    . Reductions in dead space ventilation with nasal high flow depend on physiological dead space volume: metabolic hood measurements during sleep in patients with COPD and controls. Eur Respir J 2018;51(5):1702251.

    OpenUrlAbstract/FREE Full Text
19. 19.↵
    1. Zochios V,
    2. Collier T,
    3. Blaudszun G,
    4. Butchart A,
    5. Earwaker M,
    6. Jones N,
    7. Klein AA

    . The effect of high-flow nasal oxygen on hospital length of stay in cardiac surgical patients at high risk for respiratory complications: a randomised controlled trial. Anaesthesia 2018;73(12):1478-1488.

    OpenUrl
20. 20.↵
    1. Miller AG,
    2. Gentle MA,
    3. Tyler LM,
    4. Napolitano N

    . High-flow nasal cannula in pediatric patients: a survey of clinical practice. Respir Care 2018;63(7):894-899.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Eklund WM,
    2. Scott PA

    . High-flow nasal cannula practice patterns reported by neonatologists and neonatal nurse practitioners in the United States. Adv Neonatal Care 2018;18(5):400-412.

    OpenUrl
22. 22.↵
    1. Besnier E,
    2. Hobeika S,
    3. NSeir S,
    4. Lambiotte F,
    5. Du Cheyron D,
    6. Sauneuf B,
    7. et al.

    , BoReal study group. High-flow nasal cannula therapy: clinical practice in intensive care units. Ann Intensive Care 2019;9(1):98.

    OpenUrl
23. 23.↵
    1. Li J,
    2. Fink JB,
    3. MacLoughlin R,
    4. Dhand R

    . A narrative review on trans-nasal pulmonary aerosol delivery. Crit Care 2020;24(1):506.

    OpenUrl
24. 24.↵
    1. Shen Y,
    2. Cai G,
    3. Yan J

    . Effect of high flow nasal cannula therapy may be modified by P_aO2/F_IO2 ratio in acute hypoxemic respiratory failure. Intensive Care Med 2019;45(8):1169-1170.

    OpenUrl
25. 25.↵
    1. Nielsen KR,
    2. Ellington LE,
    3. Gray AJ,
    4. Stanberry LI,
    5. Smith LS,
    6. DiBlasi RM

    . Effect of high-flow nasal cannula on expiratory pressure and ventilation in infant, pediatric, and adult models. Respir Care 2018;63(2):147-157.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Ritchie JE,
    2. Williams AB,
    3. Gerard C,
    4. Hockey H

    . Evaluation of a humidified nasal high-flow oxygen system, using oxygraphy, capnography and measurement of upper airway pressures. Anaesth Intensive Care 2011;39(6):1103-1110.

    OpenUrlPubMedWeb of Science
27. 27.↵
    1. Ari A,
    2. Fink JB

    . Effective bronchodilator resuscitation of children in the emergency room: device or interface? Respir Care 2011;56(6):882-885.

    OpenUrlFREE Full Text
28. 28.↵
    1. Morgan SE,
    2. Mosakowski S,
    3. Solano P,
    4. Hall JB,
    5. Tung A

    . High-flow nasal cannula and aerosolized β agonists for rescue therapy in children with bronchiolitis: a case series. Respir Care 2015;60(9):e161-e165.

    OpenUrlAbstract/FREE Full Text
29. 29.
    1. Valencia-Ramos J,
    2. Mirás A,
    3. Cilla A,
    4. Ochoa C,
    5. Arnaez J

    . Incorporating a nebulizer system into high-flow nasal cannula improves comfort in infants with bronchiolitis. Respir Care 2018;63(7):886-893.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Baudin F,
    2. Buisson A,
    3. Vanel B,
    4. Massenavette B,
    5. Pouyau R,
    6. Javouhey E

    . Nasal high flow in management of children with status asthmaticus: a retrospective observational study. Ann Intensive Care 2017;7(1):55.

    OpenUrl
31. 31.↵
    1. Bráunlich J,
    2. Wirtz H

    . Oral versus nasal high-flow bronchodilator inhalation in chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Deliv 2018;31(4):248-254.

    OpenUrlPubMed
32. 32.
    1. Reminiac F,
    2. Vecellio L,
    3. Bodet-Contentin L,
    4. Gissot V,
    5. Le Pennec D,
    6. Salmon Gandonniere C,
    7. et al

    . Nasal high-flow bronchodilator nebulization: a randomized cross-over study. Ann Intensive Care 2018;8(1):128.

    OpenUrl
33. 33.↵
    1. Li J,
    2. Zhao M,
    3. Hadeer M,
    4. Luo J,
    5. Fink JB

    . Dose response to transnasal pulmonary administration of bronchodilator aerosols via nasal high-flow therapy in adults with stable chronic obstructive pulmonary disease and asthma. Respiration 2019;98(5):401-409.

    OpenUrl
34. 34.↵
    1. Ammar MA,
    2. Sasidhar M,
    3. Lam SW

    . Inhaled epoprostenol through noninvasive routes of ventilator support systems. Ann Pharmacother 2018;52(12):1173-1181.

    OpenUrl
35. 35.
    1. Li J,
    2. Harnois LJ,
    3. Markos B,
    4. Roberts KM,
    5. Homoud SA,
    6. Liu J,
    7. et al

    . Epoprostenol delivered via high flow nasal cannula for ICU subjects with severe hypoxemia comorbid with pulmonary hypertension or right heart dysfunction. Pharmaceutics 2019;11(6):281.

    OpenUrl
36. 36.↵
    1. Li J,
    2. Gurnani PK,
    3. Roberts KM,
    4. Fink JB,
    5. Vines D

    . The clinical impact of flow titration on epoprostenol delivery via high flow nasal cannula for ICU patients with pulmonary hypertension or right ventricular dysfunction: a retrospective cohort comparison study. J Clin Med 2020;9(2):464.

    OpenUrl
37. 37.↵
    1. Bennett G,
    2. Joyce M,
    3. Fernández EF,
    4. MacLoughlin R

    . Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy. Intensive Care Med Exp 2019;7(1):20.

    OpenUrl
38. 38.↵
    1. Alcoforado L,
    2. Ari A,
    3. de Melo Barcelar J,
    4. Brandão SCS,
    5. Fink JB,
    6. de Andrade AD

    . Impact of gas flow and humidity on trans-nasal aerosol deposition via nasal cannula in adults: a randomized cross-over study. Pharmaceutics 2019;11(7):320.

    OpenUrl
39. 39.↵
    1. Li J,
    2. Gong L,
    3. Fink JB

    . The ratio of nasal cannula gas flow to patient inspiratory flow on trans-nasal pulmonary aerosol delivery for adults: an in vitro study. Pharmaceutics 2019;11(5):225.

    OpenUrl
40. 40.↵
    Ministry of Health in New South Wales Australia. Humidified high flow nasal cannula oxygen guideline for metropolitan paediatric wards and EDs. 2020. Available at: http://www1.health.nsw.gov.au/pds/ActivePDSDocuments/GL2016_004.pdf. Accessed November 11, 2020.
41. 41.↵
    1. Dugernier J,
    2. Hesse M,
    3. Jumetz T,
    4. Bialais E,
    5. Roeseler J,
    6. Depoortere V,
    7. et al

    . Aerosol delivery with two nebulizers through high-flow nasal cannula: a randomized cross-over single-photon emission computed tomography study. J Aerosol Med Pulm Drug Deliv 2017;30(5):349-358.

    OpenUrl